Description

Imidazo[1,5-C]Pyrimidine-7-Carboxamide, n-(1R,3R,4S)-1- CAS NO 588722-58-1 is a high-purity, stereochemically defined heterocyclic compound that serves as a critical advanced pharmaceutical intermediate. Its value lies in its precise molecular architecture, which is essential for the synthesis of targeted, high-efficacy active pharmaceutical ingredients (APIs). This compound is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutic agents, particularly within oncology and antiviral research.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex, small-molecule drug candidates targeting specific biological pathways.
• Oncology Research: Used in the development of kinase inhibitors and other targeted cancer therapies due to its imidazopyrimidine core structure.
• Antiviral Drug Development: Serves as a precursor in the synthesis of compounds designed to inhibit viral replication enzymes.
• Chemical Biology & Proteomics: Employed as a molecular scaffold or probe in the study of protein-ligand interactions and enzyme function.
• Process Chemistry & Scale-Up: Utilized in route scouting and optimization for the commercial-scale production of APIs.
• Contract Research & Manufacturing (CRAM): Supplied to CDMOs for custom synthesis projects requiring high-purity, complex intermediates.

Basic Information

Product Name	Imidazo[1,5-C]Pyrimidine-7-Carboxamide, n-(1R,3R,4S)-1-
CAS No.	588722-58-1
Molecular Formula	C9H11N5O
Molecular Weight	205.22 g/mol
Synonyms	(1R,3R,4S)-N-(Bicyclo[2.2.1]hept-5-en-2-yl)imidazo[1,5-c]pyrimidine-7-carboxamide; 1-(1R,3R,4S)-Bicyclo[2.2.1]hept-5-en-2-yl-1H-imidazo[1,5-c]pyrimidine-7-carboxamide; Imidazo[1,5-c]pyrimidine-7-carboxamide, N-(1R,3R,4S)-1,2,3,4-tetrahydro-1,4-epoxynaphthalen-9-yl-; 588722-58-1; N-[(1R,3R,4S)-Bicyclo[2.2.1]hept-5-en-2-yl]imidazo[1,5-c]pyrimidine-7-carboxamide
EINECS	Contact for details

Quality Control

Our Imidazo[1,5-C]Pyrimidine-7-Carboxamide intermediate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including chiral purity verification by HPLC, to ensure it meets the exacting standards required for pharmaceutical R&D and production. A comprehensive Certificate of Analysis (COA) detailing identity, purity (typically ≥97% by HPLC), and impurity profiles is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.